n (%) | |
Gender | |
Male | 181 (49%) |
Female | 190 (51%) |
Age at death (years: mean, SD) | 72 (14) |
Diagnosis | |
Cancer | 289 (79%) |
Non-cancer | 76 (21%) |
Place of death | |
Hospital | 164 (44%) |
Hospice | 207 (56%) |
Duration of the dying phase (hours: median, range) | 25, 0–279 |
Symptoms at the start of the CPD | |
Level of consciousness | |
Conscious | 112 (30%) |
Semiconscious | 175 (47%) |
Unconscious | 80 (22%) |
Restlessness | 132 (36%) |
Confusion | 86 (24%) |
Respiratory tract secretions | 68 (19%) |
Treatment | |
Opioid use during the last day before the start of the CPD | 282 (76%) |
Morphine equivalent daily dose (mg/24 hours) (median, range) | 75 (2–4200) |
Opioid use during the dying phase | 345 (93%) |
Morphine equivalent daily dose (mg/24 hours) (median, range) | 108 (0–10 790) |
Use of palliative sedation during the dying phase | 162 (44%) |
Fluid intake | |
Total daily fluid intake last week before start of the CPD (mL) (median, range) | 625 (125–3375) |
0–499 mL/day | 74 (22%) |
500–999 mL/day | 117 (35%) |
≥1000 mL/day | 144 (43%) |
Total daily fluid intake last day before start of the CPD (mL) (median, range) | 625 (125–2875) |
0–499 mL/day | 187 (55%) |
500–999 mL/day | 70 (21%) |
≥1000 mL/day | 81 (24%) |
Total daily fluid intake during the dying phase (mL) (median, range) | 250 (6–2250) |
0–249 mL/day | 257 (69%) |
250–499 mL/day | 61 (16%) |
≥500 mL/day | 53 (15%) |
Total daily fluid intake 48–25 hours before death (mL) (median, range) | 334 (42–2500) |
0–249 mL/day | 190 (51%) |
250–499 mL/day | 44 (12%) |
≥500 mL/day | 121 (33%) |
CPD, Care Program for the Dying.